Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-041204
Filing Date
2025-03-18
Accepted
2025-03-18 16:15:33
Documents
99
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K olma-20241231.htm   iXBRL 10-K 3828452
2 EX-1.1 olma-ex1_1.htm EX-1.1 365873
3 EX-10.14 olma-ex10_14.htm EX-10.14 299452
4 EX-10.18 olma-ex10_18.htm EX-10.18 78342
5 EX-10.25 olma-ex10_25.htm EX-10.25 739189
6 EX-10.26 olma-ex10_26.htm EX-10.26 34355
7 EX-10.27 olma-ex10_27.htm EX-10.27 25527
8 EX-19.1 olma-ex19_1.htm EX-19.1 156772
9 EX-21.1 olma-ex21_1.htm EX-21.1 3782
10 EX-23.1 olma-ex23_1.htm EX-23.1 6004
11 EX-31.1 olma-ex31_1.htm EX-31.1 16540
12 EX-31.2 olma-ex31_2.htm EX-31.2 17427
13 EX-32.1 olma-ex32_1.htm EX-32.1 9379
14 EX-32.2 olma-ex32_2.htm EX-32.2 9372
15 EX-97.1 olma-ex97_1.htm EX-97.1 57921
16 GRAPHIC img208211803_0.jpg GRAPHIC 175793
17 GRAPHIC img208211803_1.jpg GRAPHIC 1050656
18 GRAPHIC img208211803_2.jpg GRAPHIC 308959
19 GRAPHIC img208211803_3.jpg GRAPHIC 296811
20 GRAPHIC img208211803_4.jpg GRAPHIC 336672
21 GRAPHIC img208211803_5.jpg GRAPHIC 656549
22 GRAPHIC img208211803_6.jpg GRAPHIC 586163
23 GRAPHIC img208211803_7.jpg GRAPHIC 753961
24 GRAPHIC img208211803_8.jpg GRAPHIC 834621
25 GRAPHIC img208211803_9.jpg GRAPHIC 496087
26 GRAPHIC img208211803_10.jpg GRAPHIC 517900
  Complete submission text file 0000950170-25-041204.txt   29763384

Data Files

Seq Description Document Type Size
27 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT olma-20241231.xsd EX-101.SCH 1333642
101 EXTRACTED XBRL INSTANCE DOCUMENT olma-20241231_htm.xml XML 2247856
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39712 | Film No.: 25748542
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)